Da Jiang

1.1k total citations
37 papers, 380 citations indexed

About

Da Jiang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Da Jiang has authored 37 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Da Jiang's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Da Jiang is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Da Jiang collaborates with scholars based in China, United States and Australia. Da Jiang's co-authors include Yitao Jia, Lingyu Kong, Zhongxin Li, Xinjian Xu, Fang Guo, Yabin Liu, Yanni Zhang, Chao Zhang, Na Wang and Jing Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Da Jiang

34 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da Jiang China 11 175 175 88 73 45 37 380
Zhendong Qiu China 12 155 0.9× 136 0.8× 97 1.1× 73 1.0× 19 0.4× 41 475
Ahmed Khairy Egypt 12 141 0.8× 35 0.2× 109 1.2× 22 0.3× 11 0.2× 36 368
Zhujun Deng China 9 93 0.5× 46 0.3× 65 0.7× 17 0.2× 35 0.8× 15 366
Zhiyu Qiu China 12 124 0.7× 64 0.4× 81 0.9× 74 1.0× 65 1.4× 21 344
Christopher Rall United States 12 111 0.6× 221 1.3× 63 0.7× 53 0.7× 81 1.8× 18 404
Afshin Rakhsha Iran 10 35 0.2× 123 0.7× 34 0.4× 65 0.9× 30 0.7× 36 280
Yueting Li China 13 112 0.6× 44 0.3× 69 0.8× 20 0.3× 13 0.3× 36 369
Luis Cano France 10 75 0.4× 101 0.6× 47 0.5× 44 0.6× 8 0.2× 34 330
Zhi He China 9 87 0.5× 96 0.5× 16 0.2× 15 0.2× 18 0.4× 15 293

Countries citing papers authored by Da Jiang

Since Specialization
Citations

This map shows the geographic impact of Da Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Jiang more than expected).

Fields of papers citing papers by Da Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Jiang. The network helps show where Da Jiang may publish in the future.

Co-authorship network of co-authors of Da Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Da Jiang. A scholar is included among the top collaborators of Da Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da Jiang. Da Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Da, et al.. (2025). S100A8/A9 in herpes zoster neuralgia: molecular mechanisms and therapeutic perspectives. Frontiers in Immunology. 16. 1615638–1615638.
2.
Zheng, Tao, Grace Gar‐Lee Yue, Da Jiang, et al.. (2025). Proposal of a new chemical marker for the quality control of the herb Scleromitrion diffusum. Frontiers in Chemistry. 13. 1600769–1600769.
3.
Wang, Bingsheng, Lin Yang, Wei Xu, et al.. (2023). miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. Aging. 15(14). 6993–7007. 7 indexed citations
4.
Qin, Shukui, Jin Li, Haijun Zhong, et al.. (2022). Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial. British Journal of Cancer. 127(12). 2241–2248. 15 indexed citations
6.
Hong, Lei, et al.. (2022). Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: a case report. Journal of Gastrointestinal Oncology. 13(3). 1499–1504. 3 indexed citations
7.
Lü, Zhihao, Yanqiao Zhang, Qingxia Fan, et al.. (2022). Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial. The Innovation. 3(3). 100239–100239. 9 indexed citations
9.
Chakiryan, Nicholas H., Da Jiang, Elizabeth Green, et al.. (2021). Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 40(3). 107.e11–107.e17. 1 indexed citations
10.
Zhuang, Yan, Hailong Wang, Da Jiang, et al.. (2021). Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis. BMC Cancer. 21(1). 380–380. 31 indexed citations
11.
Jin, Hui, et al.. (2020). The miR-582/CD1B Axis Is Involved in Regulation of Dendritic Cells and Is Associated with Clinical Outcomes in Advanced Lung Adenocarcinoma. BioMed Research International. 2020(1). 4360930–4360930. 10 indexed citations
12.
Xu, Xinjian, Ji Lv, Fang Guo, et al.. (2020). Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway. Frontiers in Microbiology. 11. 814–814. 129 indexed citations
13.
Hong, Lei, Haijuan Wang, Junyan Wang, et al.. (2019). <p>LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint</p>. Cancer Management and Research. Volume 11. 10393–10399. 22 indexed citations
14.
Chen, Jie, et al.. (2019). [Advances of the Correlation between Driver Gene Status and Immunotherapy 
in Non-small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 22(4). 233–238.
15.
Jiang, Da, et al.. (2015). Sequence Analysis of Mutation Site of Badh2 in 27 Varieties of Fragrant Rice. 13(2). 276–280. 1 indexed citations
16.
Jiang, Da, Shuigeng Zhou, & Yi‐Ping Phoebe Chen. (2009). Compensatory ability to null mutation in metabolic networks. Biotechnology and Bioengineering. 103(2). 361–369. 11 indexed citations
17.
Zhao, Mengjun, et al.. (2007). Geochemical features and genesis of the natural gas and bitumen in paleo-oil reservoirs of Nanpanjiang Basin, China. Science in China Series D Earth Sciences. 50(5). 689–701. 16 indexed citations
18.
Jiang, Da. (2001). The CAD technologies in advanced manufacturing modes. Machinery Design and Manufacture. 1 indexed citations
19.
Jiang, Da. (2000). THE CRUST DEGASIFICATION ALONG THE HAIYUAN ACTIVE FAULT. Northwestern Seismological Journal. 2 indexed citations
20.
Jiang, Da, et al.. (2000). [Mycobacterium vaccae influences the kinetics of Th1/Th2 cells and expression of iNOS in a marine model of experimental tuberculosis].. PubMed. 23(1). 43–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026